Overview

Update
Primary Role
Founder & Principal @
Gender:
Male
Location:
Unknown
Website:
http://dosemarketing.com
Social:

Person Details

Update

Jonathan Richman is the founder and principal for Dose. Dose develops innovative software and services to solve the marketing challenges of the world's leading healthcare companies. Dose's first product, Remedy, monitors the closed healthcare social Web to find potentially harmful inaccurate information and provides a way for healthcare companies to correct this information in a practical and compliant way.

Prior to founding Dose, Jonathan was VP, Strategy & Innovation for Zipscene is a complete, digital marketing solution for restaurants designed with two simple goals: keeping their very important guests coming back and bringing in new guests. Jonathan led product development, strategy, and thought leadership efforts for Zipscene helping the company grow from 8 employees to more than 40 in just two and a half years.

Prior to joining Zipscene, Jonathan was Group Director of Insights and Planning at Possible Worldwide and was responsible for providing strategic direction and leadership for their clients. Possible Worldwide is a top ten digital marketing agency with offices in ten countries and more than 1,200 employees representing clients that include P&G, Target, Microsoft, ConAgra Foods, and Samsung.

While at Possible, Jonathan created the blog, Dose of Digital, which provides insights on digital marketing and technology in healthcare. Jonathan is a regular speaker at major marketing meetings and conventions nationally and internationally including SXSW and Social Media Week. He has been frequently interviewed and quoted in top publications including The Wall Street Journal, The Washington Post, and NPR’s “All Things Considered”.

Prior to joining Possible Worldwide in 2007, Jonathan worked at AstraZeneca Pharmaceuticals for more than 11 years, holding positions in sales, training, sales leadership, and marketing. In his latest role, Jonathan was US Brand Leader for Faslodex, a specialty injectable treatment for advanced breast cancer.

Jobs (4)

Update
Current

Founder & Principal

Jun, 2014 - Current   (over 2 years)
Past
Started
Ended
Title
Company
Jan 16, 2012
May, 2014
VP, Product Marketing
Apr, 2007
Jan 10, 2012
Group Director
Oct, 2004
Apr, 2007
Brand Leader

Education (1)

Update

Past Event Appearances (1)

Add Board & Advisor Roles

Add Memberships

Add Images